Macrocytosis as a potential parameter associated with survival after tyrosine kinase inhibitor treatment-Reference-Cited by-同舟云学术

Macrocytosis as a potential parameter associated with survival after tyrosine kinase inhibitor treatment

Published:2016-03 Issue: Volume:56 Page:101-106
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Kloth Jacqueline S.L.,Hamberg Paul,Mendelaar Pauline A.J.,Dulfer Roderick R.,van der Holt Bronno,Eechoute Karel,Wiemer Erik A.C.,Kruit Wim H.J.,Sleijfer Stefan,Mathijssen Ron H.J.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. Tyrosine kinases as targets for cancer therapy;Krause;N Engl J Med,2005

2. Hematologic toxicities of small molecule tyrosine kinase inhibitors;Barber;Target Oncol,2011

3. Macrocytosis due to treatment with sunitinib;Billemont;N Engl J Med,2007

4. Macrocytosis and cobalamin deficiency in patients treated with sunitinib;Gillessen;N Engl J Med,2007

5. Sunitinib causes macrocytosis in patients with advanced renal cell carcinoma;Price;Curr Oncol,2010

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 study;Immunotherapy;2024-08-06

2. External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations;Clinical & Experimental Metastasis;2024-02-16

3. External Validation of a Red Cell-based Blood Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Treated With First- Line Immunotherapy Combinations;2023-10-10

4. Metastatik Renal Hücreli Kanser ve Metastatik Sarkom Tedavisi Sırasında Gelişen Pazopanib İlişkili Makrositoz’un Klinik Önemi;Akdeniz Medical Journal;2023-08-22

5. The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study;Therapeutic Advances in Urology;2023-01